Some COVID-19 Molecular Diagnostics Can Skip Forward To Market For Pooled Screening
Executive Summary
The US FDA says as long as the EUA-authorized tests provide a notification with validation data and procedural information, they can be used for pooled serial screening before additional review.
You may also be interested in...
FDA Takes Steps To Help Serial Testing Efforts, Track Asymptomatic COVID-19 Cases
The agency published a supplemental template for molecular and antigen COVID-19 EUA sponsors whose product can be used for serial testing, and a fact sheet that screening program organizers can use to pick the right test.
Quest’s First Pooled Sample COVID-19 Diagnostic Test Could Save Time, Resources: FDA
US regulators gave the thumbs-up to the first COVID-19 test that pools patient samples to determine if any one of the individuals in the pool may be infected. Despite concerns such tests may be diluted and make it harder to detect the SARS-CoV-2 virus, the FDA says validation data shows it works.
Massive Family Dollar Rat Infestation Leads To Multi-State Recall
The US FDA found more than 2,000 rats at an Arkansas Family Dollar distribution center, leadingto a six-state recall for products including feminine hygiene products, contact lens cleaners and face masks.